RAF1 and neoplasm: These data establish Raf-1 as an endogenous Rok-α inhibitor operating downstream of Ras to regulate keratinocyte differentiation, and imply that caution is in order when using Rok inhibitors, especially in the treatment of Ras-driven tumours (Figure 2).